Birgit Kerber

Birgit Kerber is the Head of Innovation and Translation at EMBL-EBI and the Business Development Lead at Open Targets, where they are responsible for business development and public-private partnerships. With extensive experience in the biotech and pharma sectors, Birgit previously served as an Intellectual Property Manager and Business Development Manager at EMBL-EBI. They hold a PhD in Biology with a focus on Molecular Genetics from the Max Planck Institute and have a diverse educational background that includes business studies. Their work is driven by a passion for connecting scientific advancements with commercial opportunities to facilitate the delivery of medicines to patients.